Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara® ...Middle East

PR Newswire - News
Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara®
The clinical comparative study met its primary endpoint and showed similar efficacy and comparable safety profile in patients with moderate to severe plaque psoriasis GUANGZHOU, China, Nov. 29, 2023 /PRNewswire/ -- Bio-Thera Solutions, Ltd. (688177:SH), a commercial-stage...

Hence then, the article about bio thera solutions announces positive results from phase 3 study of bat2206 a proposed biosimilar referencing stelara was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara® )

Apple Storegoogle play

Last updated :

Also on site :